Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma. Lisle TL, Weis-Banke SE, Ahmad SM, Holmstrom MO, et al. Br J Dermatol 2025 Nov 10:ljaf450. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Lisle TL, Weis-Banke SE, Ahmad SM, Holmstrom MO, et al. Harnessing Arginase-2-specific CD8+ T cells to target immunosuppressive Cutaneous T cell Lymphoma. Br J Dermatol 2025 Nov 10:ljaf450. doi: 10.1093.
PMID: 41208405